OPB

General Information


DRACP ID  DRACP01125

Peptide Name   OPB

Sequence  GNKKWEQKQVQIKTLEGEFSVTMWSS

Sequence Length  26

UniProt ID  Q00899  P25490 

PubChem CID  Not available

Origin  YY1 protein

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma As shown in figure 3 WST-1 assay 5~6 days Patent
MDA-MB-231 Breast adenocarcinoma Carcinoma As shown in figure 4 WST-1 assay 5~6 days Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Is nontoxic to normal breast cell

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01125

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C137H214N36O42S

Absent amino acids  ACDHPRY

Common amino acids  K

Mass  351557

Pl  9.37

Basic residues  4

Acidic residues  3

Hydrophobic residues  7

Net charge  1

Boman Index  -5144

Hydrophobicity  -96.54

Aliphatic Index  52.31

Half Life 
  Mammalian: 2.8 hour
  Yeast: 10 min
  E.coli: 2 min

Extinction Coefficient cystines  11000

Absorbance 280nm  440

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN105601724B

Patent Title  Anticancer active OPB (oligopeptidase B) oligopeptide and expression vector and application thereof

Other Iinformation  Granted Patent; Family: 2s / 2ex; Family Jurisdictions: CN; Legal Status: Active; Application No: 201610018929 Filed: Jan 12, 2016 Published: Jun 7, 2019 Earliest Priority: Jan 12, 2016; Granted: Jun 7, 2019

Other Published ID  CN105601724B 




DRACP is developed by Dr.Zheng's team.